Boundless Bio Inc expected to post a loss of 58 cents a share - Earnings Preview
Boundless Bio Inc <BOLD.OQ> expected to post a loss of 58 cents a share - Earnings Preview
Boundless Bio Inc BOLD.OQ BOLD.O is expected to show no change in quarterly revenue when it reports results on August 3 (estimated) for the period ending June 30 2026
LSEG's mean analyst estimate for Boundless Bio Inc is for a loss of 58 cents per share.
The one available analyst rating on the shares is "hold".
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Boundless Bio Inc is $4.00, about 60% above its last closing price of $2.50
This summary was machine generated July 31 at 12:50 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Recent news on Boundless Bio
See all newsBoundless Bio, Inc. reports results for the quarter ended June 30 - Earnings Summary
Boundless Bio Inc expected to post a loss of 58 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Bath & Body Works, Avis Budget, Cerebras
U.S. STOCKS ON THE MOVE-Boundless Bio, Galectin, UniQure
Boundless Bio soars on merger with Serapha